败血症标记物的作用作为炎症性肠病的潜在生物标记物:一项前性观察性研究
Natsuki Ishida1, Shinya Tani1, Tomohiro Takebe1
1First Department of Medicine.
Journal of clinical gastroenterology
|January 12, 2026
概括
像IL-6,PSEP和PTX3这样的败血症标志物显示出潜在的性结肠炎 (UC) 和克罗恩病的非侵入性生物标志物.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 识别炎症性肠病 (IBD) 的非侵入性生物标志物对于改善患者管理至关重要.
- 败血症标志物,包括介质素-6 (IL-6),前素 (PSEP),前素 (PCT) 和素3 (PTX3),被评估了它们在IBD中的潜力.
研究的目的:
- 研究特定的败血症标记物作为性结肠炎 (UC) 和克罗恩病 (CD) 的生物标记物的实用性.
- 评估这些败血症标志物与UC和CD中疾病活动的既定临床和内镜测量之间的相关性.
主要方法:
- 一项前性观察性研究,涉及诊断为UC或CD的患者.
- 内镜评估和测量败血症标志物 (IL-6,PSEP,PCT,PTX3),C反应蛋白 (CRP) 和富含白的α2糖蛋白 (LRG).
- 标记水平和内镜分数之间的相关性分析 (UC的梅奥内镜子分数[MES],CD的克罗恩病简单内镜分数[SES-CD]).
主要成果:
- 在内镜分数和几个标志物之间观察到显著的相关性:UC中的MES与LRG,CRP,IL-6,PSEP和PTX3相关.
- 在CD中的SES-CD与LRG,CRP,IL-6和PTX3.3相关.
- 在UC较高的MES组中发现LRG,CRP和IL-6的水平较高,而在SES-CD≥3组中,LRG,CRP,IL-6,PSEP和PTX3的水平较高.
结论:
- 介质素-6 (IL-6) 成为UC的潜在生物标志物.
- 作为CD的生物标志物,IL-6,PSEP和PTX3显示出有希望的结果.
- 这些发现可能有助于加强IBD的管理策略.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
631
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
631
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
531
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
531
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
882
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
882
01:30Inflammatory Bowel Disease II: Crohn's Disease
945
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
945
01:29Inflammatory Bowel Disease IV: Pharmacological Management
471
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
471
01:17Irritable Bowel Syndrome I: Introduction
910
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
910